Mirimac Fund Inc

Call
301 Roaring Brook Rd
Chappaqua, NY 10514

Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, known for its sale of ONIVYDE to Ipsen S.A. in April 2017, which entitles them to contingent milestone payments. The company does not engage in ongoing research or development activities and operates without any employees, relying on external consultants for its operations.

Located at One Broadway, 14th floor in Cambridge, MA, Merrimack Pharmaceuticals focuses on managing its business through corporate governance structures, including a Board of Directors and Committee Composition. Investors can access stock information, press releases, events, presentations, SEC filings, and investor FAQs through the company's Investor Relations contact.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

United StatesNew YorkChappaquaMirimac Fund Inc